Clinical Trials Browser

Terminated × necitumumab × Thoracic × Clear all

NCT03054038 2022-04-14

Afatinib and Necitumumab in Patients With EGFR Mutation Positive Advanced or Metastatic Non-small Cell Lung Cancer

Phase 1 Terminated

Carcinoma, Non-Small-Cell Lung

NCT02443337 2020-12-09

A Study of LY3023414 and Necitumumab in Squamous Lung Cancer

Phase 2 Terminated

31 enrolled 14 charts

Non-small Cell Lung Cancer Metastatic